Valproic acid inhibits corticotropin-releasing factor synthesis and release from the rat hypothalamus in vitro: Evidence for the involvement of GABAergic neurotransmission

Journal of Psychiatry and Neuroscience

Volumn 29, Issue 6, 2004, Pages 459-466

  Tringali, Giuseppe ^a   Aubry, Jean Michel ^b   Moscianese, Katiuscia ^c   Zamori, Claudia ^a   Vairano, Maxiro ^a   Preziosi, Paolo ^a   Navarra, Pierluigi ^a   Pozzoli, Giacomo ^a  

^a CATHOLIC UNIVERSITY   (Italy)

^b GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^c ASL Roma B   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID; BICUCULLINE; CORTICOTROPIN; CORTICOTROPIN RELEASING FACTOR; METHYL IODIDE; MUSCIMOL; POTASSIUM CHLORIDE; VALPROIC ACID;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BIPOLAR DISORDER; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG MECHANISM; EXPLANT; GABAERGIC TRANSMISSION; HORMONE RELEASE; HORMONE SYNTHESIS; HYPOTHALAMUS; MALE; MOOD DISORDER; NONHUMAN; PATHOPHYSIOLOGY; RADIOIMMUNOASSAY; RAT; RIBONUCLEASE PROTECTION ASSAY; STATISTICAL ANALYSIS; STRESS;

ANIMALS; ANTICONVULSANTS; BICUCULLINE; CORTICOTROPIN-RELEASING HORMONE; DOSE-RESPONSE RELATIONSHIP, DRUG; GAMMA-AMINOBUTYRIC ACID; GENE EXPRESSION; HIPPOCAMPUS; MALE; MUSCIMOL; RATS; RATS, WISTAR; RECEPTORS, GABA-A; RNA, MESSENGER; SECRETORY RATE; SYNAPTIC TRANSMISSION; TISSUE CULTURE TECHNIQUES; VALPROIC ACID;

EID: 11344293077     PISSN: 11804882     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Vale W, Spiess J, Rivier C, Rivier J. Characterization of a 41-residue ovine hypothalamic peptide that stimulates the secretion of corticotropin and β-endorphin. Science 1981;213:1394-7.
2. Orth DN. Corticotropin-releasing hormone in humans. Endocr Rev 1992;13(4514):164-91.
3. Dinan TG. Psychoneuroendocrinology of mood disorders. Curr Opin Psychiatry 2001;14:51-5.
4. McElroy SL, Keck PE Jr, Pope HG Jr, Hudson JI. Valproate in the treatment of bipolar disorder: literature review and clinical guidelines. J Clin Psychopharmacol 1992;12(1 Suppl):42S-52S.
5. Jones MT, Gillham B, Altaher AR, Nicholson SA, Campbell EA, Watts SM, et al. Clinical and experimental studies on the role of GABA in the regulation of ACTH secretion: a review. Psychoneuroendocrinology 1984;9(2):107-23.
6. Melis GB, Mais V, Paoletti AM, Antinori D, de Ruggiero A, Fioretti P. GABAergic control of anterior pituitary function in humans. Adv Biochem Psychopharmacol 1986;42:219-42.
7. Stout SC, Owens MJ, Lindsey KP, Knight DL, Nemeroff CB. Effects of sodium valproate on corticotropin releasing factor systems in rat brain. Neuropsychopharmacology 2001;24(6):624-31.
8. Gilmor ML, Skelton KH, Nemeroff CB, Owens MJ. The effects of chronic treatment with the mood stabilizers valproic acid and lithium on corticotropin-releasing factor neuronal systems. J Pharmacol Exp Ther 2003;305(2):434-9.
9. Pozzoli G, Tringali G, Dello Russo C, Vairano M, Preziosi P, Navarra P. HIV-1 Gp120 protein modulates corticotropin releasing factor synthesis and release via the stimulation of its mRNA from the rat hypothalamus in vitro: involvement of inducible nitric oxide synthase. J Neuroimmunol 2001;118:268-76.
10. McNamara JO. Drugs effective in the therapy of the epilepsies. In: Hardman JG, Limbird LE, Gilman AG, editors. Goodman & Gilman's the pharmacological basis of therapeutics. New York: McGraw-Hill; 2001. p. 536-7.
11. Navarra P, Tsagarakis S, Faria MS, Rees LH, Besser GM, Grossman A. Interleukins-1 and -6 stimulate the release of corticotropin-releasing hormone-41 from rat hypohalamus in vitro via the eicosanoid cyclooxygenase pathway. Endocrinology 1991;128(1):37-44.
12. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chlorophorm extraction. Anal Biochem 1987;162(1):156-9.
13. Gilman M. RNase protection assay. In: Ausubel FM, Brent K, Kingston RE, Moore DD, Seidman JG, Smith JA, editors. Current protocols in molecular biology. Vol. 1. New York: Wiley and Sons; 1994. p. 4.7.1-4.7.8.
14. Pozzoli G, Bilezikjian LM, Perrin MH, Blount AL, Vale WW. Corticotropin-releasing-factor (CRF) and glucocorticoids modulate the expression of type 1 CRF receptor messenger ribonucleic acid in rat anterior pituitary cell cultures. Endocrinology 1996;137:65-71.
15. Plotsky PM, Owens MJ, Nemeroff CB. Psychoneuroendocrinology of depression: Hypothalamic-pituitary-adrenal axis. Psychiatr Clin North Am 1998;21(2):293-307.
16. Kasckow JW, Baker D, Geracioti Jr TD. Corticotropin-releasing hormone in depression and post-traumatic stress disorder. Peptides 2001;22:845-51.
17. Keck ME, Holsboer F. Hyperactivity of CRH neuronal circuits as a target for therapeutic interventions in affective disorders. Peptides 2001;22:835-44.
18. Nemeroff CB. An ever-increasing pharmacopoeia for the management of patients with bipolar disorder. J Clin Psychiatry 2000;61(Suppl 13):19-25.
19. Jones MT, Hillhouse EW, Burden J. Effect of various putative neurotransmitters on the secretion of corticotrophin-releasing hormone from the rat hypothalamus in vitro - a model of the neurotransmitters involved. J Endocrinol 1976;69:1-10.
20. Plotsky PM, Otto S, Sutton S. Neurotransmitter modulation of corticotropin relasing factor secretion into the hypophysial-portal circulation. Life Sci 1987;41(10):1311-7.
21. Tran V, Hatalski CG, Van XX, Baram TZ. Effects of blocking GABA degradation on corticotropin-releasing hormone gene expression in selected brain regions. Epilepsia 1999;40(9):1190-7.
22. Cole RL, Sawchenko PE. Neurotransmitter regulation of cellular activation and neuropeptide gene expression in the paraventricular nucleus of the hypothalamus. J Neurosci 2002;22 (3):959-69.
23. Ikeda Y, Nishiyama N, Sato H, Katsuki H. GABAA receptor stimulation promotes survival of embryonic rat striatal neurons in culture. Brain Res Dev Brain Res 1997;98:253-8.
24. Price ML, Lucki I. Regulation of serotonin release in the lateral septum and striatum by corticotropin releasing factor. J Newrosci 2001;21(8):2833-41.
25. Harwood AJ. Neurodevelopment and mood stabilizers. Curr Mol Med 2003;3(5):472-82.
26. Williams RS, Cheng L, Mudge AW, Harwood AJ. A common mechanism of action for three mood-stabilizing drugs. Nature 2002;417:292-5.
27. Roth SY, Allis CD. Hystone acetylation and chromatin assembly: a single escort, multiple dances? Cell 1996;87:5-8.
28. Graziani G, Tentori L, Portarena I, Vergati M, Navarra P. Valproic acid increases the stimulatory effect of estrogens on proliferation of human endometrial adenocarcinoma cells. Endocrinology 2003;144(7):2822-8.
29. Wood RJ, Nelson-Degrave VL, Jansen E, Mosselman S, McAllister JM, Strauss JF III. Insight into the metabolic side effects of valproic acid revealed from cDNA microarray analysis [abstract P3-37]. The Endocrine Society's 85th annual meeting; 2003 June 19-22; Philadelphia (PA).
30. Einat H, Yuan P, Gould TD, Du JH, Zhang L, Manji HK, et al. The role of the extracellular signal-regulated kinase signaling pathway in mood modulation. J Neurosci 2003;23(19):7311-6.